文献速递脑血管病

循环代谢物可区分急性缺血性卒中与卒中模拟病

Circulating Metabolites Differentiate Acute Ischemic Stroke from Stroke Mimics.
PubMed 文献 · Ann Neurol · 2020-08-29

该研究对508例缺血性卒中(IS)、349例卒中模拟病(SM)及112例神经正常对照(NC)在症状发作24小时内采血行非靶向代谢组学,采用发现-验证设计、多变量线性回归、机器学习及倾向评分匹配分析。结果发现4种代谢物(不对称/对称二甲基精氨酸、硫酸孕烯醇酮、腺苷)在复制样本中区分IS与SM的AUC达0.90,优于常规多模态头颅CT(AUC=0.80),且90天时均恢复至对照水平。

要点

  • 4种代谢物组合区分IS与SM的AUC为0.90,优于多模态头颅CT的0.80。
  • 采血中位时间为症状发作后3.3小时(IQR 1.6-6.7小时)。
  • 4种代谢物在90天时均恢复至对照水平。

核心结论

  • 一组与卒中病理生理相关的4种代谢物在患者到院时识别IS具有前所未有的效用,值得进一步多中心研究。

研究设计与样本

  • 对症状发作24小时内到院的IS患者(N=508)、SM患者(N=349,定义为MRI弥散加权成像无阳性病灶)及神经正常对照(N=112)行血清非靶向代谢组学。
  • 采用发现-验证方法,应用多变量线性回归模型、机器学习技术及倾向评分匹配进行比较。
  • 采血中位时间为症状发作后3.3小时(四分位距1.6-6.7小时)。

主要发现

  • 41种代谢物水平与IS相比NC显著相关。
  • 区分IS与SM价值最高的代谢物为不对称二甲基精氨酸、对称二甲基精氨酸、硫酸孕烯醇酮和腺苷。
  • 这4种代谢物在复制样本中区分IS与SM的AUC为0.90,优于常规诊断获得的多模态头颅CT(AUC=0.80)。
  • 这4种代谢物优于在本样本中检测到的既往发表代谢物组合。
  • 所有4种代谢物在第90天恢复至对照水平。

关键数值与推荐

  • 4种代谢物组合区分IS与SM的AUC为0.90(复制样本)。
  • 多模态头颅CT区分IS与SM的AUC为0.80。
  • 采血中位时间距症状发作3.3小时(IQR 1.6-6.7小时)。

临床怎么用

  • 该4种代谢物组合有望在患者到院时辅助识别IS,但需进一步多中心研究验证。

局限性

  • 原文未报告

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Early discrimination of patients with ischemic stroke (IS) from stroke mimics (SMs) poses a diagnostic challenge. The circulating metabolome might reflect pathophysiological events related to acute IS. Here, we investigated the utility of early metabolic changes for differentiating IS from SM. METHODS: We performed untargeted metabolomics on serum samples obtained from patients with IS (N = 508) and SM (N = 349; defined by absence of a diffusion weighted imaging [DWI] positive lesion on magnetic resonance imaging [MRI]) who presented to the hospital within 24 hours after symptom onset (median time from symptom onset to blood sampling = 3.3 hours; interquartile range [IQR] = 1.6-6.7 hours) and from neurologically normal controls (NCs; N = 112). We compared diagnostic groups in a discovery-validation approach by applying multivariable linear regression models, machine learning techniques, and propensity score matching. We further performed a targeted look-up of published metabolite sets. RESULTS: Levels of 41 metabolites were significantly associated with IS compared to NCs. The top metabolites showing the highest value in separating IS from SMs were asymmetrical and symmetrical dimethylarginine, pregnenolone sulfate, and adenosine. Together, these 4 metabolites differentiated patients with IS from SMs with an area under the curve (AUC) of 0.90 in the replication sample, which was superior to multimodal cranial computed tomography (CT; AUC = 0.80) obtained for routine diagnostics. They were further superior to previously published metabolite sets detected in our samples. All 4 metabolites returned to control levels by day 90. INTERPRETATION: A set of 4 metabolites with known biological effects relevant to stroke pathophysiology shows unprecedented utility to identify patients with IS upon hospital arrival, thus encouraging further investigation, including multicenter studies. ANN NEUROL 2020;88:736-746.

来源:Ann Neurol,查看原文。版权归原作者所有。

引用

  1. Tiedt S, Brandmaier S, Kollmeier H, et al. Circulating Metabolites Differentiate Acute Ischemic Stroke from Stroke Mimics. Ann Neurol. 2020. PMID: 32748431. doi:10.1002/ana.25859

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。